Pharmacopoeias, Pharmacy and Drug Related Works
Pharmacopeias, pharmacy, and works related to medicines constitute the regulatory and technical foundation that ensures the quality, safety, and efficacy of pharmaceutical products. Pharmacopeias are official compendiums that contain detailed standards and specifications for the manufacturing and quality control of medicines. In the field of pharmacy, these documents are essential for professionals who develop, produce, and dispense medications, ensuring they meet the required standards. At CymitQuimica, we offer an extensive collection of products and reagents that comply with the specifications of the most recognized pharmacopeias worldwide. Our catalog includes active ingredients, excipients, and reference standards, all designed to meet the needs of professionals in the field of pharmacy and pharmaceutical research, facilitating the development and production of safe and effective medications.
Found 277 products of "Pharmacopoeias, Pharmacy and Drug Related Works"
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
TILIDINE HYDROCHLORIDE HEMIHYDRATE - REFERENCE SPECTRUM
<p>TILIDINE HYDROCHLORIDE HEMIHYDRATE - REFERENCE SPECTRUM</p>FLURAZEPAM MONOHYDROCHLORIDE - REFERENCE SPECTRUM
<p>FLURAZEPAM MONOHYDROCHLORIDE - REFERENCE SPECTRUM</p>DIHYDRALAZINE SULFATE (HYDRATED) - REFERENCE SPECTRUM
<p>DIHYDRALAZINE SULFATE (HYDRATED) - REFERENCE SPECTRUM</p>European Pharmacopoeia 11th Edition (11.0-11.1-11.2) - Online Version - Bilingual
<p>Available to order from July 2022 / Effective from 1 January 2023<br><br><br>The European Pharmacopoeia (Ph. Eur.) is a single reference work for the quality control of medicines. The official standards it contains provide a scientific basis for quality control during the entire life cycle of a product.<br><br>These standards are legally binding – as laid down in the Council of Europe Convention on the Elaboration of a European Pharmacopoeia and in EU and national pharmaceutical legislation. Ph. Eur. quality standards become mandatory on the same date in all States Parties to the convention.<br><br><br>The 11th Edition at a glance<br><br> • Legally binding in 39 European countries and applied in more than 120 countries worldwide.<br> • Provides new and revised texts.<br> • Delivers crucial information for European markets earlier than any other Pharmacopoeia.<br> • The 10th Edition (including Supplement 10.5) contains 2447 monographs (including dosage forms), 378 general texts (including general monographs and methods of analysis) and about 2800 descriptions of reagents.<br><br><br>Initial release and updates<br><br>The 10th Edition of the Ph. Eur. was released in July 2019 and will be updated with eight periodic supplements over the following three years (10.1 to 10.8). <br><br>Main volume 11.0 published in July 2022,<br>Supplement 11.1 published in October 2022,<br>Supplement 11.2 published in January 2023.<br><br><br>Electronic version:<br><br> • Completely cumulative versions, bilingual (English and French), with new features and direct access to complementary information (Knowledge Database);<br> • Access to the European Pharmacopoeia Online website from all recent common operating systems (tablet and smartphone friendly);<br> • An application fully compatible with recent Windows and Linux operating systems;<br> • Two installation options for each electronic licence: either individual or shared access (one option to be chosen):<br> • Individual use: install the application on one computer and on one USB stick, for online or offline use and easy access while on the move or in environments where using the book or the website is not possible or practical;<br> • Shared use: install the application on one computer or one USB stick, for online or offline use, for example for non-nominative access in university libraries or laboratories.</p>European Pharmacopoeia 10th Edition (10.0-10.1-10.2) - Book - French
<p>La Pharmacopée Européenne (Ph. Eur.) est un ouvrage de référence unique en matière de contrôle qualité des médicaments. Les normes officielles qui y sont publiées fournissent une base scientifique au contrôle qualité durant toute la vie des médicaments.<br><br>Ces normes sont juridiquement contraignantes — ce qui est expressément stipulé dans la Convention relative à l’élaboration d’une Pharmacopée européenne et dans les législations pharmaceutiques nationales et de l’UE. Les normes qualité de la Ph. Eur. deviennent d’application obligatoire à la même date dans tous les États Parties à la convention.<br><br><br>La 10e Édition en bref<br><br> • Juridiquement contraignante dans 39 pays d’Europe et appliquée dans plus de 120 pays du monde entier<br> • Contient des nouveaux textes et des textes révisés<br> • Divulgue des informations essentielles pour les marchés européens avant toutes les autres pharmacopées<br> • La 10e Edition (Supplément 10.5 inclus) comprend 2447 monographies (y compris les formes pharmaceutiques), 378 textes généraux (y compris les monographies générales et méthodes d’analyse) et environ 2800 descriptions de réactifs.<br><br><br>Calendrier de parution<br><br>La 10e Édition de la Ph. Eur. a été publiée en juillet 2019 et sera complétée par huit suppléments périodiques (10.1 à 10.8) au cours des trois années suivantes. <br><br>Volume 10.0 publiée en juillet 2019,<br>Supplément 10.1 publiée en octobre 2019,<br>Supplément 10.2 publiée en janvier 2020.<br><br><br>Version papier<br><br>La 10e Édition est composée de trois volumes initiaux (10.0), complétés par huit suppléments non cumulatifs (10.1 à 10.8). Par souci de commodité des utilisateurs, un accès direct aux informations complémentaires (base de données Knowledge) est inclus pour chaque monographie et chaque chapitre général (code Datamatrix). Disponible en français ou en anglais, la version papier contient une clé d’activation (code EPID) qui donne accès aux archives en ligne.</p>
